Marker Therapeutics Inc (MRKR) Transcripts
Marker Therapeutics Inc to Participate in the Beyond CAR-T: What's Next for Cell Therapy Event Transcript
Aug 09, 2023
Marker Therapeutics Inc to Host Clinical Program Update Call Transcript
Feb 16, 2022
Marker Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 21, 2021
Q1 2021 Marker Therapeutics Inc Earnings Call Transcript
May 12, 2021
$21.6
(-8.47%)
Earnings
Q3 2020 Marker Therapeutics Inc Earnings Call Transcript
Nov 09, 2020
$14.9
(+2.76%)
Earnings
Marker Therapeutics Inc MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting Transcript
Jun 01, 2020
Q1 2020 Marker Therapeutics Inc Earnings Call Transcript
May 11, 2020
$24.8
(+3.12%)
Earnings
Q3 2019 Marker Therapeutics Inc Earnings Call Transcript
Nov 12, 2019
$39.2
(-2.00%)
Earnings
Marker Therapeutics Inc Special Call Transcript
Jul 22, 2019
Marker Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 16, 2019